摘要
【目的】探讨由人参、熟地、菖蒲等组成的脑还丹胶囊治疗血管性痴呆的临床疗效。【方法】将符合美国精神病学会DSM -IV诊断标准的血管性痴呆患者 4 5例 ,随机分为 2组。脑还丹组 2 2例 ,脑复康对照组 2 3例 ,分别采用脑还丹胶囊和脑复康片 (吡拉西坦 )治疗 ,疗程 3个月。采用简易精神状态检查表 (MMSE)和日常生活自理能力表 (ADL)积分变化进行疗效评估 ,检测患者治疗前后血清雌二醇 (E2 )和睾酮 (T)的水平变化。【结果】脑还丹能提高血清E2 (cE2 )和T (cT)水平 ,降低cE2 /cT 比值 (P <0 0 5 )。脑还丹组总有效率为 72 7% ,对照组为 5 6 5 % ,两组比较差异无显著性 (P >0 0 5 ) ;MMSE和ADL治疗前后差值比较 ,脑还丹组均优于对照组 (P <0 0 5或P <0 0 1)。【结论】脑还丹胶囊对血管性痴呆有较好的防治作用 ,其机理可能与提高血清E2 和T水平 ,降低cE2 /cT 比值 ,调节神经内分泌有关。
To observe the therapeutic effect of Naohuandan Capsule (mainly composed of Radix Ginseng, Radix Rehmanniae Preparata,etc.) in treating mild and moderate cases of vascular dementia (VD).Forty five cases of VD, which are subjected to the diagnostic standard of American Association of Psychiatry (DSM Ⅳ), were randomly allocated to two groups for a 3-month treatment course. Group A (n=22) was treated with Naohuandan Capsule and Group B (n=23) with Naofukang Tablet. Therapeutic effect was evaluated by scoring of mini-mental state examination (MMSE) and activity of daily living (ADL) and serum levels of estradiol (E 2) and testosterone (T) were also observed.Scores of MMSE and ADL were increased, E 2 and T levels were elevated and the ratio of E 2/T was decreased in Group A(P<0 05 or P<0 01 as compared with Group B). The total therapeutic effective rate was 72 7% in Group A and 56 5% in Group B, with nonsignificant difference (P>0 05). [Conclusion]Naohuandan Capsule has a definite effect in preventing and treating VD and its mechanism may be related to the increase of E 2 and T levels, decrease of E 2/T ratio and the regulation of neuroendocrine function.
出处
《广州中医药大学学报》
CAS
2002年第3期169-171,共3页
Journal of Guangzhou University of Traditional Chinese Medicine
基金
广东省科委 1998年重点攻关项目 (NO . 980 13 )
广东省中医药管理局科研基金资助项目 (NO . 983 88)
关键词
作用机理
脑还丹胶囊
治疗
血管性痴呆
临床观察
NAOHUANDAN CAPSULE/ther. use
DEMENTIA, VASCULAR/TCD therapy
ESTRADIOL/blood
TESTOSTERONE/blood
REINFORCING QI
NOURISHING BLOOD
EXPECTORANTS (TCD)/ther.use